LISATA THERAPEUTICS, INC. — Director's Dealing 2013

Jan 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2013-01-02

Reporting Person: May Larry Alan (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-02	Stock Option (Right to Buy)	$0.62	A	250000	Acquired	2023-01-01	Common stock, par value $0.001 per share (250000)	Direct

Footnotes

F1: On January 2, 2013 (the "Grant Date"), the Reporting Person was granted an option to purchase shares of the Issuer's common stock, subject to all of the terms and conditions of the Issuer's 2009 Amended & Restated Equity Compensation Plan. This option vests as follows: as to 20% of the shares on the Grant Date, and as to the remaining shares in 20% increments upon the achievement of certain specified business milestones.